Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Surender Juneja

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Hematological Oncology|October 29, 2021
Large granular lymphocytosis: A novel association with immunotherapyRithin Nedumannil, Surender Juneja
Pathology|May 5, 2015
Acute myeloid leukaemia and myelodysplastic syndromes with 50% or greater erythroblasts: a diagnostic conundrumEric Wong, Surender Juneja
Clinical Case Reports|April 12, 2018
Intrasinusoidal pattern of bone marrow infiltration by hepatosplenic T-cell lymphomaLiesl Ann Butler, Surender Juneja
Case Reports in Hematology|September 1, 2012
Myelodysplastic Syndrome with t(1;7) Associated with Marked Dysmegakarypoiesis & Severe Thrombocytopenia: A Case Report and Review of the LiteratureMichael Gilbertson, Annabel Tuckfield, Surender Juneja
Clinical Pathology (Thousand Oaks, Ventura County, Calif.)|March 14, 2022
Extreme Thrombocytosis in Refractory ITP Post-Splenectomy With Associated Fatal ThromboembolismRithin Nedumannil, Emma Leitinger, Surender Juneja
Journal of Clinical Pathology|January 23, 2015
How unique is pure erythroid leukaemia? A retrospective analysis of seven cases and review of the literatureEric Wong, Victoria Ling, David Westerman, et al.
Haematologica|August 5, 2005
Bone marrow plasma cell microaggregates detected by immunohistology predict earlier relapse in patients with minimal disease after high-dose therapy for myelomaAndrew Wei, David Westerman, Frank Feleppa, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 24, 2026
Secondary outcomes of the TROG 99.03 randomized trial of systemic therapy after involved-field radiotherapy in early-stage follicular lymphoma, including toxicity, relapse and second malignancy dataPhilippa Johnstone, Mathias Bressel, John F Seymour, et al.
Haematologica|July 5, 2006
The sensitivity of CD138 immunostaining of bone marrow trephine specimens for quantifying marrow involvement in MGUS and myeloma, including samples with a low percentage of plasma cellsAshley P Ng, Andrew Wei, Dinesh Bhurani, et al.
European Journal of Haematology|March 15, 2006
The prognostic impact of bone marrow involvement in patients with diffuse large cell lymphoma varies according to the degree of infiltration and presence of discordant marrow involvementJanine Campbell, John F Seymour, Jane Matthews, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Hematological Oncology|October 29, 2021
Large granular lymphocytosis: A novel association with immunotherapyRithin Nedumannil, Surender Juneja
Pathology|May 5, 2015
Acute myeloid leukaemia and myelodysplastic syndromes with 50% or greater erythroblasts: a diagnostic conundrumEric Wong, Surender Juneja
Clinical Case Reports|April 12, 2018
Intrasinusoidal pattern of bone marrow infiltration by hepatosplenic T-cell lymphomaLiesl Ann Butler, Surender Juneja
Case Reports in Hematology|September 1, 2012
Myelodysplastic Syndrome with t(1;7) Associated with Marked Dysmegakarypoiesis & Severe Thrombocytopenia: A Case Report and Review of the LiteratureMichael Gilbertson, Annabel Tuckfield, Surender Juneja
Clinical Pathology (Thousand Oaks, Ventura County, Calif.)|March 14, 2022
Extreme Thrombocytosis in Refractory ITP Post-Splenectomy With Associated Fatal ThromboembolismRithin Nedumannil, Emma Leitinger, Surender Juneja
Journal of Clinical Pathology|January 23, 2015
How unique is pure erythroid leukaemia? A retrospective analysis of seven cases and review of the literatureEric Wong, Victoria Ling, David Westerman, et al.
Haematologica|August 5, 2005
Bone marrow plasma cell microaggregates detected by immunohistology predict earlier relapse in patients with minimal disease after high-dose therapy for myelomaAndrew Wei, David Westerman, Frank Feleppa, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 24, 2026
Secondary outcomes of the TROG 99.03 randomized trial of systemic therapy after involved-field radiotherapy in early-stage follicular lymphoma, including toxicity, relapse and second malignancy dataPhilippa Johnstone, Mathias Bressel, John F Seymour, et al.
Haematologica|July 5, 2006
The sensitivity of CD138 immunostaining of bone marrow trephine specimens for quantifying marrow involvement in MGUS and myeloma, including samples with a low percentage of plasma cellsAshley P Ng, Andrew Wei, Dinesh Bhurani, et al.
European Journal of Haematology|March 15, 2006
The prognostic impact of bone marrow involvement in patients with diffuse large cell lymphoma varies according to the degree of infiltration and presence of discordant marrow involvementJanine Campbell, John F Seymour, Jane Matthews, et al.
Pageof 4